Strategic use of antibiotics in the neonatal intensive care unit

Catherine Tom-Revzon1

  • 1Arnold & Marie Schwartz College of Pharmacy and Health Sciences, Long Island University, 75 DeKalb Ave, Brooklyn, NY 11201, USA. catherine.tom@liu.edu

Insights

Neonatal infections are a major cause of infant death. Monitoring pathogen shifts and judicious antibiotic use are crucial for combating antibiotic resistance in neonatal intensive care units.

Area of Science:

  • Neonatal Medicine
  • Infectious Diseases
  • Pharmacology

Background:

  • Infections are a leading cause of morbidity and mortality in neonatal intensive care units (NICUs).
  • Therapeutic interventions like mechanical ventilation can compromise natural infection barriers.
  • Maternal and neonatal risk factors are known for early- and late-onset sepsis.

Purpose of the Study:

  • To address the challenges of increasing antibiotic resistance and shifting pathogen prevalence in NICUs.
  • To emphasize the need for strategic antibiotic use in neonatal populations.
  • To highlight the importance of developing protocols for infection control and antibiotic stewardship.

Main Methods:

  • Identification of common pathogens and their antibiotic resistance patterns.
  • Monitoring of pathogen shifts within individual NICUs.
  • Analysis of antibiotic characteristics for effective treatment selection.

Main Results:

  • Common pathogens in NICUs often exhibit resistance to traditional antibiotics.
  • Pathogen predominance can shift, necessitating changes in empiric antibiotic regimens.
  • Continuous monitoring and strategic antibiotic selection are vital for patient care.

Conclusions:

  • Modification of traditional antibiotic regimens may be required due to evolving resistance and pathogen shifts.
  • Implementing infection control measures and judicious antibiotic use guidelines is essential.
  • Developing specific protocols can minimize the threat of antibiotic resistance in NICUs.

Related Concept Videos

Clinical Significance of Antibiotic Resistance01:25

Clinical Significance of Antibiotic Resistance

Methicillin-resistant Staphylococcus aureus (MRSA) presents a critical public health threat, arising from its capacity to resist β-lactam antibiotics due to acquisition of the mecA gene within the staphylococcal cassette chromosome mec (SCCmec). This gene encodes penicillin-binding protein 2a (PBP2a), which impairs binding efficacy of methicillin and other β-lactams. MRSA has evolved into distinct clonal lineages impacting humans and animals alike, reinforcing its significance within the One...
Microbiota Modulation by Antibiotics01:21

Microbiota Modulation by Antibiotics

Antibiotics have revolutionized modern medicine by saving countless lives from bacterial infections. However, their widespread use has inadvertently harmed the delicate balance of the human gut microbiota. The gut microbiota, a complex community of bacteria, archaea, viruses, and fungi, plays a vital role in regulating metabolism, immune responses, and maintaining intestinal health. Antibiotics, especially broad-spectrum types, disrupt this ecosystem by eradicating both harmful and beneficial...
Mechanism of Antibiotic Resistance in MRSA01:25

Mechanism of Antibiotic Resistance in MRSA

Antibiotic resistance in bacteria arises when microorganisms evolve the ability to withstand drugs designed to kill them or inhibit their growth, rendering once-effective treatments useless. This phenomenon, driven by genetic change and selection under antibiotic exposure, poses a profound threat to modern medicine. Mechanisms include drug-inactivating enzymes (e.g., β-lactamases), efflux pumps that eject antibiotics, mutations altering antibiotic targets, decreased drug uptake, and acquisition...
Combined Effects of Drugs: Synergism01:27

Combined Effects of Drugs: Synergism

Synergism is a useful mechanism where combining two or more drugs is more effective than each constituent used alone. Such combinations are also called supra-additive interactions. The drugs collectively enhance the final therapeutic effect by acting on different targets. Another advantage is that the low dose of each constituent drug is sufficient to achieve the desired effect. This helps reduce the duration of therapy and lower the adverse effects of these drugs.
Such synergistic combinations...
Antibiotic Selection00:57

Antibiotic Selection

Overview
Healthcare Associated Infections II: Preventive Measures01:22

Healthcare Associated Infections II: Preventive Measures

Essential infection prevention measures are based on the knowledge of the infection chain, the modes of transmission in healthcare settings, and the use of the best practices in all healthcare settings. Compulsory public reporting of healthcare-associated infection rates is needed to allow individuals and the community to make informed choices regarding selecting a healthcare facility.
The best practices for preventing healthcare-associated infections include hand hygiene, patient risk...